EARN25

Put Buying Picks Up During Regeneron Stock Rally

Regeneron Pharmaceuticals shares are staying hot

Dec 13, 2019 at 2:45 PM
facebook X logo linkedin


Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has been rallying hard since its lows near $270 from early October, checking in 0.9% higher today at $375.40 -- which would be its best close since April -- after Credit Suisse this morning upgraded its rating to $400 from $340. This comes after REGN stock broke through the 320-day moving average last month, with the shares now sporting a three-month gain of 33.3%. During this surge, options traders have turned to long puts.

Specifically, the 10-day put/call volume ratio at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) checks in at 1.02 -- the first time long puts have outpaced long calls in this time frame since July. The current reading falls into the 92nd annual percentile, underscoring the strangeness of the trading action.

We should also point out that short interest keeps grinding higher on REGN, so sentiment is growing somewhat cautious outside the options pits, as well. In the last two reporting periods, short interest rose 11.3%, now at 2.36 million shares --  more than three times the average daily trading volume.

regn putcall ratio dec 13

 

You Don’t Need 25 Alerts -- You Need ONE You Can Trust!

That’s the idea behind Trade of the Week, Schaeffer’s newest trade alert.

Every Monday morning before the opening bell, you’ll receive a single, expertly researched trade recommendation -- built from the same proprietary research we’ve been using for over four decades.

It’s not just a signal.

It’s a plan designed for traders who are tired of jumping from alert to alert without ever finding their edge.

No juggling alerts. No switching directions mid-week. Just one clear, expertly researched trade idea -- delivered before the market even opens.

👉 JOIN RIGHT NOW FOR JUST $1 TO GET THE NEXT TRADE!